ArticleGhana medical journal2025
Perinatal outcome of pregnant mothers with active rubella infection in a tertiary hospital in Nigeria.
Article in Ghana medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To determine the seroprevalence of the rubella virus among pregnant women and the perinatal outcome of neonates of mothers with active rubella virus. Design: A cross-sectional and longitudinal study. Setting: The study was conducted in the Obstetrics and Gynaecology Department of a teaching hospital in Nigeria. Participants: Pregnant women at the gestational age of 18-20 weeks. Intervention: Screening pregnant mothers for immunoglobulin (IgG, IgM) for the rubella virus. Neonates of pregnant mothers with active rubella infection (IgM positive) were screened at birth for rubella IgM to assess for congenital rubella infections and congenital rubella syndrome. Main outcome measure: Prevalence of rubella immunoglobulin G and active rubella infection IgM, congenital rubella infection, and congenital rubella syndrome. Results: Of the 327 participants, 68.8% were rubella IgG seropositive, while 7.6% were Rubella IgM seropositive. Fifty-six (56) per cent of neonates of women with active rubella infection were Rubella IgM seropositive at birth, and 14.3% of the neonates of Rubella IgM seropositive pregnant women with active rubella infection had occipitofrontal circumference of less than 10 Conclusion: Rubella virus is present in our environment with the risk of pregnant mother and neonate of being infected. Funding: None declared.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.